Ecuador vs Saudi Arabia: Previously treated cases tested for RR-/MDR-TB
Ecuador
97.0%
in 2024
Saudi Arabia
98.0%
in 2024
Ecuador rank
61st
Saudi Arabia rank
58th
Previously treated cases tested for RR-/MDR-TB over time
- Ecuador
- Saudi Arabia
How they compare
Saudi Arabia currently reports 98.0% against 97.0% in Ecuador, a difference of 1.0%.
The two have swapped places 1 time across 7 shared years of data; in 2013 it was Ecuador ahead.
Ecuador ranks 61st and Saudi Arabia ranks 58th of 180 countries.
Ecuador has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ecuador | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 77.8% | 38.1% | 39.6% | Ecuador |
| 2020s | 97.3% | 75.3% | 22.0% | Ecuador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Ecuador or Saudi Arabia?
- Saudi Arabia, at 98.0% against 97.0% in Ecuador as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Ecuador and Saudi Arabia?
- 1.0%, with Saudi Arabia ahead.
- How many years of comparable data are there for Ecuador and Saudi Arabia?
- 7 years are reported by both, from 2013 to 2024.
- How do Ecuador and Saudi Arabia rank globally for previously treated cases tested for rr-/mdr-tb?
- Ecuador ranks 61st and Saudi Arabia ranks 58th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.